B-Cell Biology - WMUK webinar

preview_player
Показать описание
Dr Gina Doody joins us to talk about B-cell biology, the subject of her research.
  1. WMUK
Рекомендации по теме
B-Cell Biology - 1:11:19

B-Cell Biology - WMUK webinar

WMUK Webinar - 0:47:11

WMUK Webinar - When Waldenstrom's macroglobulinaemia transforms

BTK inhibitors in 1:20:41

BTK inhibitors in Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia Management 1:32:02

Waldenstrom Macroglobulinemia Management Webinar

Waldenstrom's macroglobulinaemia (WM) 1:26:57

Waldenstrom's macroglobulinaemia (WM) education webinar

How does Waldenstrom's 0:01:12

How does Waldenstrom's macroglobulinaemia develop?

2020 IWMF Global 0:55:21

2020 IWMF Global Educational Webinar: How Understanding Precursors can Help in Finding a Cure

Waldenstrom's Macroglobulinaemia for 0:47:55

Waldenstrom's Macroglobulinaemia for beginners with Dr Jin Lindsay

December 7, 2022 1:03:26

December 7, 2022 CLLAN Webinar: Understanding different BTK targeted CLL treatments

2018 WMFC Ed 0:50:23

2018 WMFC Ed Forum Halifax Dr. Shirley D'Sa

Waldenstrom's Macroglobulinemia 2023 1:17:15

Waldenstrom's Macroglobulinemia 2023

Kayson Tang - 0:04:59

Kayson Tang - Waldenstrom Macroglobulinemia - AP BIO

Waldenstrom’s Macroglobulinemia: Advances 0:43:03

Waldenstrom’s Macroglobulinemia: Advances in Treatments

Diagnosis and Treatment 0:48:43

Diagnosis and Treatment of Cryoglobulinemic Vasculitis – ERKNet Webinar with Dario Roccatello

Unmet needs in 0:02:08

Unmet needs in CLL: managing immune complications and patients with high-risk disease

LncRNA expression in 0:01:41

LncRNA expression in IgM MGUS: a potential malignant driver for WM?

Risk Factors in 0:03:36

Risk Factors in Developing Waldenström Macroglobulinemia

The importance of 0:01:07

The importance of genomic testing and analysis in Waldenström’s macroglobulinemia

Waldenström Macroglobulinemia: Rare, 0:25:46

Waldenström Macroglobulinemia: Rare, but treatable – An Interview with Dr Shirley D’Sa

The recent FDA 0:01:12

The recent FDA approval of cilta-cel and its impact on myeloma patients in the UK

Overview of Waldenström’s 0:03:18

Overview of Waldenström’s Macroglobulinemia

Challenges associated with 0:04:07

Challenges associated with Waldenström’s

Improving Patient Outcomes 0:57:44

Improving Patient Outcomes through Discovery: WM with Dr. Steve Treon (Spanish)

The clinical application 0:01:52

The clinical application of genomics in Waldenström's macroglobulinemia